Each study, in date order
TB-500 is the short piece; most thymosin beta-4 studies used the full protein.
You will start with actin, then read the wound, heart, and brain findings. Each result names what scientists tested.
The full protein holds actin in a 1:1 pair
An X-ray test used gelsolin-domain-1, a lab tool that kept the parts still. Full thymosin beta-4 held loose actin in the image. By covering both ends, the protein kept actin from building a longer strand. The image reached 2 Å, or two ten-billionths of a meter [1]. Scientists could then see where thymosin beta-4 made contact.
This hold saves actin until a cell must move. Cell movement helps close a wound and mend tissue. TB-500 has only one part of the hold. It would be wrong for you to assume the fragment also carries useful parts found elsewhere in the protein.
TB-500 is only one piece of thymosin beta-4
Thymosin beta-4 is a 43-amino-acid protein, so it is built from many small parts. Blood cells release it beside an injury [5]. TB-500 is one man-made part of that protein. It matches parts 17 to 23, the place that holds actin, while all other parts are absent.
A wide review looked at the complete thymosin beta-4 protein [5]. It helped cells move and reduced the cells that form scars. After harm, it also slowed cell death, swelling, and germ growth. Small new blood vessels appeared. That work led to studies of the heart, brain, skin, and eyes. Tests of the fragment haven't produced all those findings [5].
Another fact makes the gap clearer for you. The complete protein can give off a different small piece [5]. That second piece may curb scars and aid new blood vessels. It comes from the far end of thymosin beta-4, so TB-500 cannot make it. Ads that call TB-500 and thymosin beta-4 equal go beyond the evidence.
TB-500 side effects remain unknown in long-term human use
Cancer research gives one reason for care. Some people with colon or pancreas cancer have high levels of full thymosin beta-4. Other work links that protein with cancer spread and extra blood vessels [5]. Moving cells can close wounds, yet the same act might feed a tumor. Studies have proved neither that harm nor long-term safety for people using the fragment.
The small human safety test used only full thymosin beta-4. Phase 1, the first safety stage, gave healthy adults up to 1260 mg by vein. No dose stopped, and the study found no grave side effect [6]. The test lasted just 14 days. It cannot settle long use, use by sick people, or use of the small piece.
Two animal results also call for care. Thymosin beta-4 produced new muscle fibers in mice born with a disease that wastes muscle. Strength, heart action, and scar tissue did not improve [5]. After stroke, rats improved on 2 and 12 milligrams for each kilogram they weighed. At 18 milligrams for each kilogram, the rats weren't helped [4]. This finding gives no backing to "loading," or taking more at the start.
TB-500 and BPC-157 are two different compounds
TB-500 and BPC-157 aren't two labels for one compound. TB-500 comes from one small section of thymosin beta-4. BPC-157 is a separate man-made chain with its own parts. Researchers have suggested another way it could act [5]. People pair the two because both appear in repair work.
A 2026 Sports Medicine review covered TB-500/thymosin beta-4 and BPC-157 [10]. Animal tissue results sometimes looked good, while sound human safety work stayed scarce. The review also warned of a chance for grave harm. Neither compound is approved for these uses. That gives you the newest outside review of both.
Animal studies found some gains and some clear limits
The studies below name the animal or person tested, so you can place each finding. They also tell you whether the test used the short piece or the full protein.
TB-500 heart benefits haven't been shown in people
In mice with a tied heart artery, full thymosin beta-4 helped young heart cells live. Heart cells also moved, while the animals' hearts pumped better [2]. The study traced several steps inside those cells. Testing thymosin beta-4 in pigs found no drop in harm after blood flow returned. A separate human trial used thymosin beta-4 after a sudden heart attack [8]. None proves a heart benefit from the small piece.
TB-500 brain protection hasn't been proved in humans
Male rats had a blocked brain artery, much like a stroke. Belly shots of full thymosin beta-4 gave 2 milligrams per kilogram, 12 milligrams per kilogram, or 18 milligrams per kilogram. Shots began 24 hours after the stroke, then came every 3 days for four more doses. From day 14 through day 56, movement improved with 2 milligrams per kilogram and 12 milligrams per kilogram. The 18 milligrams per kilogram group got no clear help. A math estimate favored ~3.75 milligrams per kilogram [4]. Researchers never tested that exact amount, and more did not help.
TB-500: rats had better ligament repair, while people remain untested
Researchers injured a rat's knee ligament, then saw more repair after giving thymosin beta-4 [5]. Very few direct tests support the sports-recovery claim. No fair human trial shows that TB-500 mends a tendon or ligament. For your decision, the support comes from animal work and full-protein effects on cell travel and scars [5].
TB-500: new mouse fibers did not improve muscle strength
Animal work found thymosin beta-4 drawing young muscle cells into hurt tissue. Mice born with a disease that wastes muscle grew new fibers, but stayed just as weak [5]. No gain has been shown in people using the fragment. A 2021 study found thymosin beta-4 entering the blood during exercise [11]. That finding calls for more work. It is not a result that can guide your recovery choice.
No study says how fast TB-500 works in people
Researchers have not measured a healing wait in people. Rats received full thymosin beta-4 after wounds went through the skin. New skin cover was 42% higher at 4 days and up to 61% higher at 7 days when set against salt water [3]. An animal received the whole protein here. The study can't set a time for when TB-500 might affect you.
Human trials used full protein rather than TB-500
Scientists have completed no fair human test of the TB-500 seven-part piece [5]. Human work used full thymosin beta-4. A Phase 1 trial, an early safety test, tracked side effects after vein use [6]. Eye drops called RGN-259 reached dry-eye trials [7]. A shot after a sudden heart attack finished another trial [8]. An early test of a heart-attack shot was withdrawn before anyone joined [9].
Newer TB-500 and thymosin beta-4 work tests delivery and detection
Work from 2021–2026 asked several questions. In 2025, researchers packed the complete protein inside tiny sacs made by cells, then placed the sacs in a gel. Wounded tissue formed blood vessels [12]. Another 2025 study paired the protein with selenium for diabetic sores [13]. A third 2025 team joined small protein pieces for eye-surface wounds [16]. A 2024 drug check measured TB-500 and the material remaining once it broke apart [15]. A 2026 Sports Medicine paper reviewed unapproved peptides used after muscle or joint harm [10]. See the new TB-500 and thymosin beta-4 work.
Exercise releases thymosin beta-4 into the blood
A 2021 study found thymosin beta-4 entering people's blood during exercise [11]. In plain terms, the body released the protein while people were active. The protein also helps cells grow. Those facts may explain the interest in sports recovery. They don't show that adding TB-500 helps a person recover.